Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Shumande Pharmaceutical Technology Development is a China-based contract research organization focused on clinical research services for the pharmaceutical and healthcare industry. The company supports new drug clinical trials across Phase 1 through Phase 4, bioequivalence studies, post-marketing studies, and related medical writing, statistics, pharmacovigilance, and clinical operations services. Public descriptions emphasize strength in chronic-disease-related programs and coverage across multiple specialties including dermatology, ophthalmology, psychiatry, and endocrinology. Shumande appears to operate as a service provider rather than a product-developing biotech, with broad experience across small molecules, biologics, cell therapy, and traditional Chinese medicine-related studies. It is an active private company headquartered in Beijing with affiliated operations in Harbin and additional national office coverage in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Shumande Pharmaceutical Technology Development.